Company Profile

MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders.

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian Cboe Exchange under the symbol MMED.

Industry Classifications

Sector:
Healthcare

Industry:
Biotechnology

NAICS:
Medicinal and Botanical Manufacturing (325411)

SIC:
Medicinal Chemicals and Botanical Products (2833)

Contact Information

Investor Relations
Chris Brinzey
ICR Westwicke
ir@mindmed.co

Company Contact
Mind Medicine (MindMed) Inc.
One World Trade Center
Suite 8500
New York, NY 10007
United States